share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股SEC公告 ·  06/04 16:25
Moomoo AI 已提取核心信息
SeaStar Medical Holding Corporation, a company listed on The Nasdaq Stock Market under the trading symbol ICU, held a virtual Special Meeting of stockholders on June 4, 2024. During the meeting, stockholders voted on several key proposals. Three Class II Directors were elected to serve until the 2027 annual meeting: Allan Collins, MD, Jennifer A. Baird, and Bernadette N. Vincent. An amendment and restatement of the Company's 2022 Omnibus Equity Incentive Plan was approved, increasing the authorized shares of common stock from 3,278,457 to 9,778,457. Additionally, the issuance of more than 20% of the Company's outstanding shares of Common Stock upon exercise of Series A and Series B Warrants was approved, in compliance with Nasdaq Listing Rule 5635(d). The appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was also ratified.
SeaStar Medical Holding Corporation, a company listed on The Nasdaq Stock Market under the trading symbol ICU, held a virtual Special Meeting of stockholders on June 4, 2024. During the meeting, stockholders voted on several key proposals. Three Class II Directors were elected to serve until the 2027 annual meeting: Allan Collins, MD, Jennifer A. Baird, and Bernadette N. Vincent. An amendment and restatement of the Company's 2022 Omnibus Equity Incentive Plan was approved, increasing the authorized shares of common stock from 3,278,457 to 9,778,457. Additionally, the issuance of more than 20% of the Company's outstanding shares of Common Stock upon exercise of Series A and Series B Warrants was approved, in compliance with Nasdaq Listing Rule 5635(d). The appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was also ratified.
SeaStar Medical Holding Corporation是一家在纳斯达克上市的公司，交易代码为ICU。公司于2024年6月4日举行了一次虚拟特别股东大会。在会议上，股东对几个关键提案进行了投票。三名II类董事被选举为公司董事，任期至2027年年度股东大会：Allan Collins，MD，Jennifer A. Baird和Bernadette N. Vincent。公司2022年股权激励全权委托计划的一项修正和重述得到了批准，将普通股的授权股数从3,278,457股增加到9,778,457股。此外，公司向协议A和协议B认股权行权发行超过20%的已发行股票得到批准，符合纳斯达克上市规则5635（d）的要求。任命WithumSmith + Brown，PC为独立注册的公共会计师事务所，负责截至2024年12月31日的财政年度审计也得到了批准。
SeaStar Medical Holding Corporation是一家在纳斯达克上市的公司，交易代码为ICU。公司于2024年6月4日举行了一次虚拟特别股东大会。在会议上，股东对几个关键提案进行了投票。三名II类董事被选举为公司董事，任期至2027年年度股东大会：Allan Collins，MD，Jennifer A. Baird和Bernadette N. Vincent。公司2022年股权激励全权委托计划的一项修正和重述得到了批准，将普通股的授权股数从3,278,457股增加到9,778,457股。此外，公司向协议A和协议B认股权行权发行超过20%的已发行股票得到批准，符合纳斯达克上市规则5635（d）的要求。任命WithumSmith + Brown，PC为独立注册的公共会计师事务所，负责截至2024年12月31日的财政年度审计也得到了批准。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息